Carleen Klumpp‐Thomas
-
- Computational Drug Discovery Methods 11
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 3
- Biophysics top 10%
-
- Protein Degradation and Inhibitors 5
-
- Cholinesterase and Neurodegenerative Diseases 4
- Pharmacogenetics and Drug Metabolism 3
-
- Innovative Microfluidic and Catalytic Techniques Innovation 3
-
- Cancer Genomics and Diagnostics 3
- Partner nations
- United StatesUnited KingdomHungary
In The Last Decade
Carleen Klumpp‐Thomas
34 papers receiving 849 citations
Peers
Comparison fields: 5 of 107
- Computational Theory and Mathematics 262
- Infectious Diseases 298
- Biophysics 30
- Molecular Biology 322
- Pharmacology 37
Countries citing papers authored by Carleen Klumpp‐Thomas
This map shows the geographic impact of Carleen Klumpp‐Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carleen Klumpp‐Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carleen Klumpp‐Thomas more than expected).
Fields of papers citing papers by Carleen Klumpp‐Thomas
This network shows the impact of papers produced by Carleen Klumpp‐Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carleen Klumpp‐Thomas. The network helps show where Carleen Klumpp‐Thomas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carleen Klumpp‐Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 6 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 20 | |
| 8 | 2022 | 6 | |
| 9 | 2021 | 29 | |
| 10 | 2021 | 107 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 35 | |
| 13 | 2020 | 17 | |
| 14 | 2020 | 18 | |
| 15 | 2020 | 6 | |
| 16 | 2020 | 152 | |
| 17 | 2019 | 22 | |
| 18 | 2019 | 12 | |
| 19 | 2018 | 63 | |
| 20 | 2017 | 9 |
About Carleen Klumpp‐Thomas
Carleen Klumpp‐Thomas is a scholar working on Computational Theory and Mathematics, Infectious Diseases and Biophysics, having authored 37 papers that have together received 855 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (11 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Protein Degradation and Inhibitors (5 papers), Cholinesterase and Neurodegenerative Diseases (4 papers), Innovative Microfluidic and Catalytic Techniques Innovation (3 papers), COVID-19 Clinical Research Studies (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Computational Theory and Mathematics (262 citations), Infectious Diseases (298 citations) and Biophysics (30 citations). Carleen Klumpp‐Thomas has collaborated with scholars based in United States, United Kingdom and Hungary. Frequent co-authors include Sam Michael, Paul Shinn, Min Shen, Wei Zheng, Hui Guo, Catherine Z. Chen, Matthew D. Hall, Miao Xu, Ruili Huang and Wei Zhu. Their work appears in journals such as Nature Communications, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.